Sol Gel Technologies Ltd (SLGL)

Currency in USD
81.7300
-0.5200(-0.63%)
Closed·
81.99000.0000(0.00%)
·
Advertisement
Earnings results expected today
Unusual trading volume
SLGL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
81.540083.7500
52 wk Range
12.500097.9700
Key Statistics
Prev. Close
82.25
Open
83.27
Day's Range
81.54-83.75
52 wk Range
12.5-97.97
Volume
86.18K
Average Volume (3m)
36.59K
1-Year Change
528.6923%
Book Value / Share
15.73
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SLGL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
193.0000
Upside
+136.14%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Sol Gel Technologies Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 193.0000
(+136.14% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy110.00+34.59%-Maintain20/07/2026
Mizuho
Buy285.00+248.71%-New Coverage24/06/2026
TD Cowen
Buy---New Coverage29/05/2026
H.C. Wainwright
Buy110.00+34.59%50.00Maintain20/01/2026
H.C. Wainwright
Buy50.00-38.82%6.00Maintain27/10/2025

Earnings

Latest Release
28/05/2026
EPS / Forecast
1.31 / -1.84
Revenue / Forecast
108K / 900K
EPS Revisions
Last 90 days

Compare SLGL to Peers and Sector

Metrics to compare
SLGL
Peers
Sector
Relationship
P/E Ratio
−256.8x−0.2x−0.4x
PEG Ratio
−2.790.000.00
Price/Book
5.2x2.2x2.6x
Price / LTM Sales
14.5x2.3x3.0x
Upside (Analyst Target)
123.7%47.4%56.0%
Fair Value Upside
Unlock18.1%9.1%Unlock

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
21.03K0.64%1.73M
Other Institutional Investors
1.70M51.89%139.53M
Public Companies & Retail Investors
1.55M47.46%127.61M
Total
3.27M100.00%268.87M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Opaleye Management Inc.15.57%508,93641,860
Opaleye L.P15.11%493,93640,626

People Also Watch

13.57
MPAA
+1.27%
4.320
SILO
+3.10%
3.23
CURR
-6.92%
71.69
TRNO
+0.06%
3.520
PODC
+3.83%

FAQ

What Is the Sol Gel Tech (NASDAQ: SLGL) Share Price Today?

The Sol Gel Tech stock price today is 81.7300 USD.

What Stock Exchange Does Sol Gel Tech (SLGL) Trade On?

Sol Gel Tech is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Sol Gel Tech?

The stock symbol (also called a 'ticker') for Sol Gel Tech is "SLGL."

What Is the Current Sol Gel Tech Market Capitalisation?

As of today, Sol Gel Tech (NASDAQ: SLGL) market cap is 268.3800M USD.

What Is Sol Gel Tech's (SLGL) Earnings Per Share (TTM)?

The Sol Gel Tech EPS is currently -0.3738 (Trailing Twelve Months).

When Is the Next Sol Gel Tech Earnings Date?

Sol Gel Tech's next earnings report will be released on 03/08/2026.

Is SLGL a Buy or Sell From a Technical Analyst Perspective?

Based on today's Sol Gel Tech moving averages and other technical indicators, the daily buy/sell signal for SLGL stock is Buy.

How Many Times Has Sol Gel Tech Stock Split?

Sol Gel Tech has split 1 times. (See the SLGL stock split history page for full effective split date and price information.)

How Many Employees Does Sol Gel Tech Have?

Sol Gel Tech has 28 employees, based on their latest Companies House report.

What is the current trading status of Sol Gel Tech (NASDAQ: SLGL)?

As of 03/08/2026, Sol Gel Tech (SLGL) is trading at a share price of 81.7300 USD, with a previous close of 82.2500 USD. The stock has fluctuated within a day range of 81.5400 USD to 83.7500 USD, while its 52-week range spans from 12.5000 USD to 97.9700 USD.

What Is Sol Gel Tech (SLGL) Price Target According to Analysts?

The average 12-month price target for Sol Gel Tech is 193.0000 USD, with a high estimate of 285 USD and a low estimate of 110 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +136.14% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.